Florence ABRAVANEL

assistant professor

Centre Hospitalier Universitaire de Toulouse

France

Research Interests

Explore related searches

Professors in France Professors in Immunology Immunology professors in France

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Florence Abravanel is an assistant professor at the Centre Hospitalier Universitaire de Toulouse, France. Her research focuses on virology, particularly the detection and characterization of hepatitis E virus (HEV) and its impact on host organisms, as well as advances in automated virological platforms. Recent publications include studies on CMV, EBV, and BKPyV DNA detection, as well as investigations into the prevalence and transmission of HEV in various populations.

Articles (23)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (2)

Jacques Izopet

Toulouse University Hospital

FRANCE

View details

Nassim Kamar

Toulouse University Hospital

FRANCE

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Florence ABRAVANEL

Research Interests

Explore related searches

Contact this professor

About

Articles (23)

Performance of an automated platform for CMV, EBV and BKPyV DNA detection and quantification

Increase in HEV IgG Seroprevalence During the Past Years in Southern France

Large-scale HEV genotype 3 outbreak on New Caledonia Island

Porcine-derived pancreatic enzyme replacement therapy: a cause of hepatitis E virus transmission?

Characterization of virus-host recombinant variants of the hepatitis E virus

Evaluation of an automated platform for the detection of HEV RNA in plasma and stool

Hecolin vaccine: long-term efficacy against HEV for a three-dose regimen

Hepatitis E Virus Infection in a Pregnant Liver Transplant Recipient Leading to Chronic Infection

Increased Prevalence of Antibodies to Hepatitis E Virus in Patients with Neurocysticercosis

The Conversion From Mycophenolic Acid to Mammalian Target of Rapamycin Inhibitor Reduces the Incidence of Cytomegalovirus Replication in Belatacept-Treated Kidney-Transplant Recipients

Clustered Cases of Waterborne Hepatitis E Virus Infection, France

Diagnostic and management strategies for chronic hepatitis E infection

Glucocorticoids selectively affect the memory T cell response to SARS-Cov2 spike in vaccinated and post-infected patients with systemic lupus erythematosus

Seven years (2015-2021) of blood donor screening for HEV-RNA in France: lessons and perspectives

Unmet Needs for the Treatment of Chronic Hepatitis E Virus Infection in Immunocompromised Patients

Humoral and Cellular Responses to a Delayed Fourth SARS-CoV-2 mRNA-Based Vaccine in Weak Responders to 3 Doses Kidney Transplant Recipients

Diagnostic Performance of an Automated System for Assaying Anti-Hepatitis E Virus Immunoglobulins M and G Compared with a Conventional Microplate Assay

Diagnostic Performance of an Automated System for Assaying Anti-Hepatitis E Virus Immunoglobulins M and G Compared with a Conventional Microplate Assay

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients

Anti-SARS-CoV-2 spike protein and neutralizing antibodies at 1 and 3 months after three doses of SARS-CoV-2 vaccine in a large cohort of solid organ transplant patients

Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine

Humoral and Cellular Immune Responses of Solid Organ Transplant Patients on Belatacept to Three Doses of mRNA-Based Anti-SARS-CoV-2 Vaccine

Influence of the Delta Variant and Vaccination on the SARS-CoV-2 Viral Load

Collaborators (2)

Jacques Izopet

Nassim Kamar

Make your next move.